Last reviewed · How we verify
NCT05548049
Autogenous Ramus Bone Block Harvesting With Piezosurgery
NA trial testing Bone harvesting from ramus area with piezosurgery for autogenous bone augmentation in Alveolar Bone Resorption in 19 participants. Completed in 1 July 2022.
1 March 2022
Quick facts
| Lead sponsor | Marmara University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 19 |
| Start date | 1 September 2021 |
| Primary completion | 1 March 2022 |
| Estimated completion | 1 July 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Bone harvesting from ramus area with piezosurgery for autogenous bone augmentation
- Bone harvesting from ramus area with conventional burs for autogenous bone augmentation
Conditions studied
- Alveolar Bone Resorption — all drugs for Alveolar Bone Resorption →
Sponsor
Marmara University
Who can join
Adults 18 to 65, any sex, with Alveolar Bone Resorption. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this randomized prospective clinical trial was to evaluate the outcome of bone block harvesting from the retromolar region using the Conventional and Piezosurgery Method. The study was planned on 19 patients (13F,6M) on 31 donor sites. In patients with bilateral bone harvesting, the donor site and the surgical method to be used were determined by the randomization protocol, while in patients with bone harvesting from a single site, the donor site was determined by considering parameters such as proximity to the operation site and distance to the inferior alveolar nerve. Clinical parameters such as operation time, pain, swelling, trismus, nerve damage were evaluated.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A randomized controlled trial comparing conventional and piezosurgery methods in mandibular bone block harvesting from the retromolar region.
Bayram F, Demirci A. · · 2023 · cited 2× · PMID 38071300 · DOI 10.1186/s12903-023-03739-9
Verify or expand the search:
- PubMed search for NCT05548049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alveolar Bone Resorption
Currently open trials in the same condition.
- NCT07404098 — Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized P · NA · active not recruiting
- NCT05937035 — Histological and Volumetric Evaluation of Customized Allograft Bone Blocks · NA · recruiting
- NCT07028606 — Vertical Ridge Augmentation Using Computer-guided Sandwich Osteotomy Technique · Phase 1 · active not recruiting
- NCT05577663 — Guided Bone Regeneration in Alveolar Socket · NA · recruiting
Other Marmara University trials
Trials by the same sponsor.
- NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
- NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
- NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05548049 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marmara University
- Last refreshed: 21 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05548049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing